PT1100767E - Derivados de feniletilemina processo para a sua preparacao e sua utilizacao como medicamento - Google Patents

Derivados de feniletilemina processo para a sua preparacao e sua utilizacao como medicamento

Info

Publication number
PT1100767E
PT1100767E PT99938314T PT99938314T PT1100767E PT 1100767 E PT1100767 E PT 1100767E PT 99938314 T PT99938314 T PT 99938314T PT 99938314 T PT99938314 T PT 99938314T PT 1100767 E PT1100767 E PT 1100767E
Authority
PT
Portugal
Prior art keywords
phenylethylmine
medication
preparing
derivatives process
derivatives
Prior art date
Application number
PT99938314T
Other languages
English (en)
Inventor
Birke Dr Franz
Ralf Anderskewitz
Hans Michael Jennewein
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of PT1100767E publication Critical patent/PT1100767E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PT99938314T 1998-07-31 1999-07-22 Derivados de feniletilemina processo para a sua preparacao e sua utilizacao como medicamento PT1100767E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19834713A DE19834713A1 (de) 1998-07-31 1998-07-31 Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
PT1100767E true PT1100767E (pt) 2002-11-29

Family

ID=7876091

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99938314T PT1100767E (pt) 1998-07-31 1999-07-22 Derivados de feniletilemina processo para a sua preparacao e sua utilizacao como medicamento

Country Status (13)

Country Link
US (1) US6133479A (pt)
EP (1) EP1100767B1 (pt)
JP (1) JP2002522411A (pt)
AR (1) AR019975A1 (pt)
AT (1) ATE221043T1 (pt)
AU (1) AU5286499A (pt)
CA (1) CA2338649C (pt)
DE (2) DE19834713A1 (pt)
DK (1) DK1100767T3 (pt)
ES (1) ES2177308T3 (pt)
PE (1) PE20000866A1 (pt)
PT (1) PT1100767E (pt)
WO (1) WO2000007977A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834713A1 (de) * 1998-07-31 2000-02-03 Boehringer Ingelheim Pharma Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10344447A1 (de) * 2003-09-25 2005-05-12 Degussa Verfahren zur Herstellung O-alkylierter Aminoalkohole
ATE481968T1 (de) * 2004-07-14 2010-10-15 Inflammation Res Ct Company Lt Verfahren zur hemmung von tumormetastasierung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4424714A1 (de) * 1994-07-13 1996-01-18 Boehringer Ingelheim Kg Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff
DE4424713A1 (de) * 1994-07-13 1996-01-18 Boehringer Ingelheim Kg Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe
US5585492A (en) * 1994-10-11 1996-12-17 G. D. Searle & Co. LTA4 Hydrolase inhibitors
DE19718334A1 (de) * 1997-04-30 1998-11-05 Boehringer Ingelheim Pharma Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19834713A1 (de) * 1998-07-31 2000-02-03 Boehringer Ingelheim Pharma Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
AU5286499A (en) 2000-02-28
AR019975A1 (es) 2002-03-27
CA2338649A1 (en) 2000-02-17
ES2177308T3 (es) 2002-12-01
JP2002522411A (ja) 2002-07-23
CA2338649C (en) 2008-10-14
DK1100767T3 (da) 2002-11-11
EP1100767A1 (de) 2001-05-23
DE59902136D1 (de) 2002-08-29
PE20000866A1 (es) 2000-09-05
DE19834713A1 (de) 2000-02-03
US6133479A (en) 2000-10-17
WO2000007977A1 (de) 2000-02-17
ATE221043T1 (de) 2002-08-15
EP1100767B1 (de) 2002-07-24

Similar Documents

Publication Publication Date Title
PT1218341E (pt) Derivados de sulfonilcarboxamidas, processo para a sua preparacao e sua utilizacao como medicamentos
PT1124810E (pt) Derivados 2-amino-tiazole, processo para a sua preparacao e sua utilizacao como agentes anti-tumorais
PT1325001E (pt) Novos anticolinergicos aplicaveis como medicamentos e processo para a sua preparacao
PT1294682E (pt) Derivados de acilfenilureia processo para a sua preparacao e sua aplicacao como medicamentos
BR9909313B1 (pt) Sistema terapêutico transdérmico, processo para a preparação de um sistema terapêutico transdérmico, e, produto
BR9707839A (pt) Primido-Ú5,4-D¾-primidas medicamentos contendo esses compostos sua aplicação e processo para a sua preparação
PT1232152E (pt) Processo melhorado para a preparacao de aminotetralinas substituidas no azoto
PT1086092E (pt) Derivados de 1,1-dioxido-benzo (b) tiepina processo para a sua producao medicamentos contendo esses compostos e a sua utilizacao
PT1256584E (pt) Processo para a preparacao de adefovir-dipivoxil
BR9606782A (pt) Processo para preparar ciclopilacetileno
PT1038899E (pt) PROMOTOR DE ADESAO PARA REFORCOS TêXTEIS INTERNOS PROCESSO PARA A SUA PRODUCAO E A SUA UTILIZACAO
PT1147075E (pt) Processo para a preparacao de cloridrato de l-fenilefrina
BR9605410A (pt) Processo para preparar nicotinamida
BR9711340A (pt) Composto composi-Æo farmac-utica e processo para preparar um composto
PT1098891E (pt) Aminas tiazolidin-2-ilideno policiclicas processo para a sua preparacao e sua utilizacao como medicamento
BR9707811A (pt) Processo para preparação de um composto e composto
PT903339E (pt) Bifenilsulfonilcianamidas processos para a sua preparacao e sua utilizacao como medicamentos
PT1015421E (pt) Novos derivados de fenilamidina processo para a sua preparacao e sua utilizacao como medicamentos
PT1015433E (pt) 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocin-10-ois substituidos processo para a sua producao e sua utilizacao como medicamentos
BR9714066B1 (pt) processo para a preparaÇço de derivados de tiazol, bem como intermediÁrios e processos para sua preparaÇço.
PT1053224E (pt) Bifenilsulfonilcianamida, processo para a sua preparacao e sua utilizacao como medicamento
PT1200414E (pt) Processo para a preparacao de pirimidnas substituidas
PT1086077E (pt) Novos antiestrogeneos processo para a sua preparacao e sua utilizacao farmaceutica
PT1157020E (pt) 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocin-10-ois substituidos processo para a sua preparacao e sua utilizacao como medicamentos
PT906326E (pt) Novos derivados aromaticos substituidos por ribose processo para a sua preparacao e sua utilizacao como medicamentos